Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
PTC Therapeutics is a leading US-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for patients with rare genetic disorders and cancers. The company is dedicated to addressing unmet medical needs and improving the quality of life for people worldwide through advanced drug development.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
PTC Therapeutics is scheduled to report its next quarterly earnings on 10/22/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
PTC Therapeutics last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.92 USD.
Across its last 3 earnings reports, PTC Therapeutics stock moved by ±7.1% on average the following day. The largest reaction was +14.3% on 05/07/2026; 3 of 3 reactions were positive.
PTC Therapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.